This inventor holds 1 USPTO granted patent. Top assignee: Cell Therapeutics, Inc.. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Emer Clarke: Innovator in Allergy Treatment
Introduction
Emer Clarke is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of allergy treatment through his innovative research and development.
Latest Patents
Emer Clarke holds a patent for a method aimed at inhibiting mast cell and basophil activation. This method is designed for treating or preventing allergies or allergic disorders. It involves administering an effective amount of a compound that inhibits the intracellular generation of phosphatidic acid and diacylglycerol. The generation of these compounds is a result of allergen presentation or mast cell/basophil activation.
Career Highlights
Emer Clarke is currently associated with Cell Therapeutics, Inc., where he continues to advance his research in allergy treatments. His work has the potential to significantly improve the quality of life for individuals suffering from allergic conditions.
Collaborations
Emer collaborates with talented professionals in his field, including Elisa Eiseman and Jack W. Singer. Their combined expertise contributes to the innovative environment at Cell Therapeutics, Inc.
Conclusion
Emer Clarke's contributions to allergy treatment through his patented methods highlight his role as an important inventor in the medical field. His work continues to pave the way for advancements in allergy management.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile